Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
189 A clear increase in TILs and modest tumor growth inhibition by pembrolizumab in prostate cancer tumors growing in bone of CD34+ engrafted NOG mice
Compose a Response to This Article
Other responses
No responses have been published for this article.
